1. Home
  2. ASRT vs HLVX Comparison

ASRT vs HLVX Comparison

Compare ASRT & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • HLVX
  • Stock Information
  • Founded
  • ASRT 1995
  • HLVX 2020
  • Country
  • ASRT United States
  • HLVX United States
  • Employees
  • ASRT N/A
  • HLVX N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • HLVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASRT Health Care
  • HLVX Health Care
  • Exchange
  • ASRT Nasdaq
  • HLVX Nasdaq
  • Market Cap
  • ASRT 78.3M
  • HLVX 92.9M
  • IPO Year
  • ASRT 1997
  • HLVX 2022
  • Fundamental
  • Price
  • ASRT $0.84
  • HLVX $1.86
  • Analyst Decision
  • ASRT Strong Buy
  • HLVX Hold
  • Analyst Count
  • ASRT 4
  • HLVX 5
  • Target Price
  • ASRT $3.19
  • HLVX $2.33
  • AVG Volume (30 Days)
  • ASRT 341.2K
  • HLVX 169.4K
  • Earning Date
  • ASRT 03-10-2025
  • HLVX 03-19-2025
  • Dividend Yield
  • ASRT N/A
  • HLVX N/A
  • EPS Growth
  • ASRT N/A
  • HLVX N/A
  • EPS
  • ASRT N/A
  • HLVX N/A
  • Revenue
  • ASRT $125,763,000.00
  • HLVX N/A
  • Revenue This Year
  • ASRT N/A
  • HLVX N/A
  • Revenue Next Year
  • ASRT $1.84
  • HLVX N/A
  • P/E Ratio
  • ASRT N/A
  • HLVX N/A
  • Revenue Growth
  • ASRT N/A
  • HLVX N/A
  • 52 Week Low
  • ASRT $0.73
  • HLVX $1.55
  • 52 Week High
  • ASRT $1.80
  • HLVX $20.22
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 50.64
  • HLVX 45.95
  • Support Level
  • ASRT $0.78
  • HLVX $1.67
  • Resistance Level
  • ASRT $0.88
  • HLVX $1.97
  • Average True Range (ATR)
  • ASRT 0.03
  • HLVX 0.08
  • MACD
  • ASRT 0.01
  • HLVX -0.01
  • Stochastic Oscillator
  • ASRT 61.60
  • HLVX 51.91

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About HLVX HilleVax Inc.

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

Share on Social Networks: